Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

428.26 0.17 −0.04%
Market cap
$92.9B
P/E
19.0×
Fwd P/E
20.3×
Dividend yield
1.60%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100

Elevance Health, Inc. (ELV) Operating cash flow

Alert me on Operating cash flow

Elevance Health, Inc.'s operating cash flow for fiscal 2025 was $4.3B, down 26.1% from $5.8B in fiscal 2024. Over the twelve months to 30 June 2026 it was $7.5B. Over the past ten years it has ranged from $3.3B (fiscal 2016) to $10.7B (fiscal 2020); the current reading is higher than 45% of that period. Operating cash flow has fallen for 3 consecutive fiscal years. Elevance Health, Inc. ranks 5th of 12 Healthcare Plans companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $4.3B (26.14%)
FY2024 $5.8B (27.95%)
FY2023 $8.1B (4.02%)
FY2022 $8.4B 0.42%
FY2021 $8.4B (21.74%)
FY2020 $10.7B 76.34%
FY2019 $6.1B 58.37%
FY2018 $3.8B (8.55%)
FY2017 $4.2B 27.98%
FY2016 $3.3B (22.36%)

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $1.9B (55.84%)
Mar 2026 $4.3B 5,057.14%
Dec 2025 $84.0M (92.60%)
Sep 2025 $1.1B (44.74%)
42 more quarters

Against its own ten years

Low $3.3B High $10.7B
Ten-year median $5.8B
Current reading's percentile 45

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on ELV